David Goldstein

14PUBLICATIONS

66CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples life courseCancer geneticsMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 21, 2026

HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer.

|Apr 23, 2026

Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

|Jun 16, 2025

The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|Apr 08, 2025

Navigating pain and appetite challenges in palliative care for pancreatic cancer: insights from a national, longitudinal consecutive cohort study.

Mariana S Sousa, Maja Villanueva Garcia, Megan Blanchard

|Mar 29, 2023

Irradiation-Induced Dysbiosis: The Compounding Effect of High-Fat Diet on Metabolic and Immune Functions in Mice.

Briana K Clifford, Nadia M L Amorim, Nadeem O Kaakoush

|Jul 09, 2022

Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.

Megan C Best, Nicci Bartley, Christine E Napier

Pageof 3

Frequent Collaborators

Megan C Best

Mandy L Ballinger

David Thomas

Phyllis Butow

Nicole Bartley

Christine Napier

Ilona Juraskova

Ainsley J Newson

Bettina Meiser

Jacqueline Savard

Frequent Collaborators

Megan C Best

Mandy L Ballinger

David Thomas

Phyllis Butow